Two-stage designs versus European scaled average designs in bioequivalence studies for highly variable drugs: Which to choose?
1989 ◽
Vol 47
◽
pp. 368-369
Keyword(s):
1975 ◽
Vol 4
(11)
◽
pp. 1021-1032